MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF
Methods and compositions are provided for extending the half-life of a therapeutic agent A modified therapeutic agent (mTA) comprises a therapeutic agent, a staple, and a half-life extending molecule. The mTAs disclosed herein may be used to treat a disease or a condition in a subject in need thereof.
1 - 7 . (canceled)
8 . A peptide comprising an amino acid sequence of any one of SEQ ID NO: 30-32, 35-41, or 52-53.
9 . The peptide of claim 8 , comprising the amino acid sequence of any one of SEQ ID NO: 30-32.
10 . The peptide of claim 8 , comprising the amino acid sequence of SEQ ID NO: 35.
11 . The peptide of claim 8 , comprising the amino acid sequence of SEQ ID NO: 36.
12 . The peptide of claim 8 , comprising the amino acid sequence of SEQ ID NO: 37.
13 . The peptide of claim 8 , comprising the amino acid sequence of SEQ ID NO: 38.
14 . The peptide of claim 8 , comprising the amino acid sequence of SEQ ID NO: 39.
15 . The peptide of claim 8 , comprising the amino acid sequence of SEQ ID NO: 40.
16 . The peptide of claim 8 , comprising the amino acid sequence of SEQ ID NO: 41.
17 . The peptide of claim 8 , comprising the amino acid sequence of SEQ ID NO: 52.
18 . The peptide of claim 8 , comprising the amino acid sequence of SEQ ID NO: 53.
19 . A peptide comprising an amino acid sequence of any one of SEQ ID NO: 42-51.
20 . The peptide of claim 19 , comprising the amino acid sequence of any one of SEQ ID NO: 42-48.
21 . The peptide of claim 19 , comprising the amino acid sequence of SEQ ID NO: 49.
22 . The peptide of claim 19 , comprising the amino acid sequence of SEQ ID NO: 50.
23 . The peptide of claim 19 , comprising the amino acid sequence of SEQ ID NO: 51.